[fcb5af]: / literature / by_gene / TLR2.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 34471502 10.1016/j.csbj.2021.08.019 2022 The molecular feature of macrophages in tumor immune microenvironment of glioma patients. TLR2
2 35345353 10.31557/APJCP.2022.23.3.823 2022 Clinical Implication of Toll-Like Receptors (TLR2 and TLR4) Polymorphisms in Adult Patients with Acute B-cell Lymphoblastic Leukemia. TLR2
3 35715478 10.1038/s41598-022-14004-4 2022 Elevated expression of TLR2 and its correlation with disease activity and clinical manifestations in adult-onset Still's disease. TLR2
4 35818037 10.1186/s12906-022-03660-8 2022 Qin Huang formula enhances the effect of Adriamycin in B-cell lymphoma via increasing tumor infiltrating lymphocytes by targeting toll-like receptor signaling pathway. TLR2
5 25610736 10.4161/21624011.2014.947892 2021 Two in one: improving synthetic long peptide vaccines by combining antigen and adjuvant in one molecule. TLR2
6 32008135 10.1007/s10875-020-00760-3 2021 Human BCL10 Deficiency due to Homozygosity for a Rare Allele. TLR2
7 32041862 10.1136/bmjopen-2019-034629 2021 Third-generation anti-CD19 chimeric antigen receptor T-cells incorporating a TLR2 domain for relapsed or refractory B-cell lymphoma: a phase I clinical trial protocol (ENABLE). TLR2
8 32378684 10.1039/d0fo00575d 2021 Polysaccharides from Enteromorpha prolifera protect against carbon tetrachloride-induced acute liver injury in mice via activation of Nrf2/HO-1 signaling, and suppression of oxidative stress, inflammation and apoptosis. TLR2
9 32598477 10.1182/bloodadvances.2019001350 2021 Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis. TLR2
10 32970964 10.1165/rcmb.2020-0083OC 2021 <i>Aspergillus</i> <i>fumigatus</i> Recognition by Dendritic Cells Negatively Regulates Allergic Lung Inflammation through a TLR2/MyD88 Pathway. TLR2
11 33757561 10.1186/s13104-021-05521-y 2021 HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) versus adult T-cell leukemia/lymphoma (ATLL). TLR2
12 33776761 10.3389/fphar.2021.602676 2021 Pharmacogenetics-Based Preliminary Algorithm to Predict the Incidence of Infection in Patients Receiving Cytotoxic Chemotherapy for Hematological Malignancies: A Discovery Cohort. TLR2
13 34113355 10.3389/fimmu.2021.684424 2021 Hippo Pathway Counter-Regulates Innate Immunity in Hepatitis B Virus Infection. TLR2
14 29723986 10.3390/cancers10050129 2020 EBV Positive Diffuse Large B Cell Lymphoma and Chronic Lymphocytic Leukemia Patients Exhibit Increased Anti-dUTPase Antibodies. TLR2
15 30930876 10.3389/fmicb.2019.00475 2020 Clinical Significance of Polymorphisms in Immune Response Genes in Hepatitis C-Related Hepatocellular Carcinoma. TLR2
16 32359574 10.1016/j.psj.2019.10.034 2020 Gut microbiota mediates the protective role of Lactobacillus plantarum in ameliorating deoxynivalenol-induced apoptosis and intestinal inflammation of broiler chickens. TLR2
17 29458388 10.1186/s13045-018-0572-x 2019 A novel generation 1928zT2 CAR T cells induce remission in extramedullary relapse of acute lymphoblastic leukemia. TLR2
18 31123885 10.1007/978-3-030-15138-6_3 2019 Genetic Polymorphisms in Inflammatory and Other Regulators in Gastric Cancer: Risks and Clinical Consequences. TLR2
19 26405015 10.1038/cdd.2015.104 2018 MALT1 is an intrinsic regulator of regulatory T cells. TLR2
20 27183918 10.18632/oncotarget.9303 2018 HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2. TLR2
21 27780938 10.18632/oncotarget.12816 2018 Toll-like receptor agonists partially restore the production of pro-inflammatory cytokines and type I interferon in Sézary syndrome. TLR2
22 27059597 10.4049/jimmunol.1502297 2017 B Cell Anergy Modulated by TLR1/2 and the miR-17∼92 Cluster Underlies the Indolent Clinical Course of Chronic Lymphocytic Leukemia Stereotyped Subset #4. TLR2
23 27123851 10.1371/journal.pone.0153823 2017 Toll-Like Receptor 1/2 and 5 Ligands Enhance the Expression of Cyclin D1 and D3 and Induce Proliferation in Mantle Cell Lymphoma. TLR2
24 27343564 10.1016/j.jinf.2016.04.040 2017 Baseline cytokine profiling identifies novel risk factors for invasive fungal disease among haematology patients undergoing intensive chemotherapy or haematopoietic stem cell transplantation. TLR2
25 25886362 10.1186/s12974-015-0294-8 2016 Intravenous immunoglobulin (IVIg) dampens neuronal toll-like receptor-mediated responses in ischemia. TLR2
26 26294727 10.3324/haematol.2014.119933 2016 Toll-like receptor stimulation in splenic marginal zone lymphoma can modulate cell signaling, activation and proliferation. TLR2
27 26372276 10.1097/QAD.0000000000000687 2016 Dysregulated B-cell TLR2 expression and elevated regulatory B-cell frequency precede the diagnosis of AIDS-related non-Hodgkin lymphoma. TLR2
28 26779828 10.1038/labinvest.2015.156 2016 The pro-inflammatory role of high-mobility group box 1 protein (HMGB-1) in photoreceptors and retinal explants exposed to elevated pressure. TLR2
29 24950688 10.1158/2326-6066.CIR-13-0223 2015 Efficient induction of antitumor immunity by synthetic toll-like receptor ligand-peptide conjugates. TLR2
30 25596131 10.1016/j.bbrc.2015.01.011 2015 Pam2 lipopeptides systemically increase myeloid-derived suppressor cells through TLR2 signaling. TLR2
31 25850245 2015 [The diagnostic of defects of inborn immunity under B-cell tumors of lymphatic system]. TLR2
32 25867213 10.1002/eji.201444874 2015 Heterodimer-specific TLR2 stimulation results in divergent functional outcomes in B-cell precursor acute lymphoblastic leukemia. TLR2
33 23666053 10.1007/s11033-013-2513-7 2014 Polymorphisms and haplotypes in MyD88 are associated with the development of sarcoidosis: a candidate-gene association study. TLR2
34 24899179 10.1128/JVI.00841-14 2014 The gammaherpesviruses Kaposi's sarcoma-associated herpesvirus and murine gammaherpesvirus 68 modulate the Toll-like receptor-induced proinflammatory cytokine response. TLR2
35 24912772 10.1007/s00277-014-2131-z 2014 Toll-like receptor 2 and 9 genetic polymorphisms and the susceptibility to B cell Non-Hodgkin Lymphoma in Egypt. TLR2
36 23722608 10.1097/QAI.0b013e31829d4d50 2013 TLR2-activated B cells are phenotypically similar to the abnormal circulating B cells seen preceding the diagnosis of AIDS-related NHL diagnosis. TLR2
37 24145436 10.1073/pnas.1314608110 2013 Landscape of somatic mutations and clonal evolution in mantle cell lymphoma. TLR2
38 21951393 10.1684/ejd.2011.1544 2012 Functional and phenotypical alterations of polymorphonuclear cells in Sézary syndrome patients. TLR2
39 22134717 10.1038/leu.2011.341 2012 Polymorphisms in the TLR6 gene associated with the inverse association between childhood acute lymphoblastic leukemia and atopic disease. TLR2
40 22384669 2012 [Toll-like receptors expression on Burkitt lymphoma cells]. TLR2
41 20438785 10.1016/j.humimm.2010.04.004 2011 Polymorphisms in innate immunity genes and risk of childhood leukemia. TLR2
42 20802178 10.2353/ajpath.2010.100245 2011 TLR2-mediated expansion of MDSCs is dependent on the source of tumor exosomes. TLR2
43 21390214 10.1371/journal.pone.0014729 2011 Extracellular administration of BCL2 protein reduces apoptosis and improves survival in a murine model of sepsis. TLR2
44 19773279 10.1136/oem.2008.044024 2010 Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity. TLR2
45 20164415 10.4049/jimmunol.0901156 2010 MyD88 adaptor-like D96N is a naturally occurring loss-of-function variant of TIRAP. TLR2
46 20452489 10.1016/j.ajog.2010.03.024 2010 A genomic and proteomic investigation of the impact of preimplantation factor on human decidual cells. TLR2
47 20520640 10.1038/leu.2010.118 2010 Differential expression of NF-kappaB target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanism. TLR2
48 20800061 10.1016/j.yexmp.2010.08.003 2010 Differential expression of Toll-like receptors in follicular lymphoma, diffuse large B-cell lymphoma and peripheral T-cell lymphoma. TLR2
49 19029192 10.1093/carcin/bgn262 2009 A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma. TLR2
50 19124758 10.4049/jimmunol.182.2.1146 2009 Differential use of CARD9 by dectin-1 in macrophages and dendritic cells. TLR2
51 19573080 10.1111/j.1365-2141.2009.07790.x 2009 Common genetic variants in candidate genes and risk of familial lymphoid malignancies. TLR2
52 18175935 10.1248/bpb.31.13 2008 Dissociation of Toll-like receptor 2-mediated innate immune response to Zymosan by organic solvent-treatment without loss of Dectin-1 reactivity. TLR2
53 16899594 10.1158/1078-0432.CCR-06-0154 2007 Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma. TLR2
54 16971956 10.1038/sj.gene.6364337 2007 Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk. TLR2
55 17229603 2007 Toll-like receptors 2, 4 and 9 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome). TLR2
56 17696935 10.1111/j.1478-3231.2007.01542.x 2007 Up-regulation of proproliferative genes and the ligand/receptor pair placental growth factor and vascular endothelial growth factor receptor 1 in hepatitis C cirrhosis. TLR2
57 16412017 10.1111/j.1365-2141.2005.05893.x 2006 Differential immune effects mediated by Toll-like receptors stimulation in precursor B-cell acute lymphoblastic leukaemia. TLR2